Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
01/05/2025
Goldman Sachs: Maintains buy rating on NeoGenomics (NEO.US), adjusting target price from $15.00 to $10.00.
Latest
3 m ago
Microsoft's Chief Financial Officer: Demand has remained stable up until April.
3 m ago
Dollar bond movement | Sun Hung Kai Properties SUNHUN 1.89 01/17/28 price decreased by 1.471% to 94.372.
4 m ago
The China Meteorological Administration lifted the blue alert for strong winds at 6 a.m. on May 1st.
4 m ago
China Meteorological Administration lifted the blue alert for severe convective weather at 6:00 on May 1st.
5 m ago
Leerink Partners: Downgrades Regulus Therapeutics (RGLS.US) from outperform to market perform, with a target price of $7.00.
See all latest